FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 326:1661-1665 June 18, 1992 Number 25 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

BACKGROUND. Bronchial hyperresponsiveness to cholinergic stimuli such as the inhalation of methacholine is common in patients with impaired left ventricular function. Such hyperresponsiveness is best explained by cholinergic vasodilation of blood vessels in the small airways, with extravasation of plasma due to high left ventricular filling pressure. Because this vasodilation may be prevented by the inhalation of the vasoconstrictor agent methoxamine, we studied the effect of methoxamine on exercise performance in patients with chronic left ventricular dysfunction. METHODS. We studied 19 patients with a mean left ventricular ejection fraction of 22 +/- 4 percent and moderate exertional dyspnea. In the first part of the study, we performed treadmill exercise tests in 10 patients (group 1) at a constant maximal workload to assess the effects of 10 mg of inhaled methoxamine on the duration of exercise (a measure of endurance). In the second part of the study, we used a graded exercise protocol in nine additional patients (group 2) to assess the effects of inhaled methoxamine on maximal exercise capacity and oxygen consumption. Both studies were carried out after the patients inhaled methoxamine or placebo given according to a randomized, double-blind, crossover design. RESULTS. In group 1, the mean (+/- SD) duration of exercise increased from 293 +/- 136 seconds after the inhalation of placebo to 612 +/- 257 seconds after the inhalation of methoxamine (P = 0.001). In group 2, exercise time (a measure of maximal exercise capacity) increased from 526 +/- 236 seconds after placebo administration to 578 +/- 255 seconds after methoxamine (P = 0.006), and peak oxygen consumption increased from 18.5 +/- 6.0 to 20.0 +/- 6.0 ml per minute per kilogram of body weight (P = 0.03). CONCLUSIONS. The inhalation of methoxamine enhanced exercise performance in patients with chronic left ventricular dysfunction. However, the improvement in the duration of exercise at a constant workload (endurance) was much more than the improvement in maximal exercise capacity assessed with a progressive workload. These data suggest that exercise-induced vasodilation of airway vessels may contribute to exertional dyspnea in such patients. Whether or not inhaled methoxamine can provide long-term benefit in patients with heart failure will require further study.

Source Information

Department of Cardiology, Hopital Cochin, Rene Descartes University, Paris, France.

This article has been cited by other articles:

• Miller, J. D., Hemauer, S. J., Smith, C. A., Stickland, M. K., Dempsey, J. A. (2006). Expiratory threshold loading impairs cardiovascular function in health and chronic heart failure during submaximal exercise. J. Appl. Physiol. 101: 213-227 [Abstract] [Full Text]  
• Horvath, G., Wanner, A. (2006). Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma. Eur Respir J 27: 172-187 [Abstract] [Full Text]  
• Blanc, F.-X., Langeron, O., Coirault, C., Salmeron, S., Lambert, F., Riou, B., Lecarpentier, Y. (2004). Mechanical Properties of Tracheal Smooth Muscle Are Impaired in the Rabbit With Experimental Cardiac Pressure Overload. Chest 125: 236-242 [Abstract] [Full Text]  
• Laghi, F., Tobin, M. J. (2003). Disorders of the Respiratory Muscles. Am. J. Respir. Crit. Care Med. 168: 10-48 [Abstract] [Full Text]  
• HUGHES, P. D., HART, N., HAMNEGÅRD, C.-H., GREEN, M., COATS, A. J. S., MOXHAM, J., POLKEY, M. I. (2001). Inspiratory Muscle Relaxation Rate Slows during Exhaustive Treadmill Walking in Patients with Chronic Heart Failure. Am. J. Respir. Crit. Care Med. 163: 1400-1403 [Abstract] [Full Text]  
• Faggiano, P, D'Aloia, A, Gualeni, A, Giordano, A (2001). Relative contribution of resting haemodynamic profile and lung function to exercise tolerance in male patients with chronic heart failure. Heart 85: 179-184 [Abstract] [Full Text]  
• Duguet, A., Tantucci, C., Lozinguez, O., Isnard, R., Thomas, D., Zelter, M., Derenne, J.-P., Milic-Emili, J., Similowski, T. (2000). Expiratory flow limitation as a determinant of orthopnea in acute left heart failure. J Am Coll Cardiol 35: 690-700 [Abstract] [Full Text]  
• Wannamethee, S. G., Shaper, A. G., Ebrahim, S. (1995). Respiratory Function and Risk of Stroke. Stroke 26: 2004-2010 [Abstract] [Full Text]  
• Moore, D. P., Weston, A., Hughes, J. M. B., Oakley, C. M., Cleland, J. G.F., Cabanes, L., Costes, F., Weber, S. (1993). Bronchial Hyperresponsiveness in Heart Failure. NEJM 328: 1424-1425 [Full Text]